Administration of GLP-1 or GLP-1RAs (including exenatide, geniposide, liraglutide, lixisenatide, and semaglutide) enhances neurogenesis in the dentate gyrus, hippocampus, olfactory bulb, and medial striatum in animal models, while modulating apoptotic pathways and increasing animal survival under extreme factors [24]
From Facebook ads to YouTube testimonials, PEAKA GLP-1 & NAD+ Essence Liquid Pearls are being pushed as a miraculous health solution
Federal law allows states to exclude agents used for weight loss from their Medicaid formularies so covering GLP-1s for obesity is optional, not required
2022 Feb 25;13(1):1057
Over the next two decades, formulations evolved toward longer-acting, once-weekly injections with greater potency